Method of addressing alzheimer's disease or non-alzheimer's dementia
AssigneeG. Nofar Food Agency Ltd.
InventorGil NOFAR
Life of this patent
Estimating the term…
Abstract
A method for treating, attenuating the progression, or delaying the onset of clinical symptoms, of Alzheimer's disease or non-Alzheimer's includes administering a therapeutically effective amount of a composition comprising tahina and probiotic bacteria to a subject. The composition is formulated for oral administration; and the tahina has been microfluidized by passing through a fixed-geometry homogenization channel at a pressure of at least 5000 PSI.
Claims24
A method for treating, attenuating the progression, preventing, or delaying the onset of clinical symptoms, of Alzheimer's disease or non-Alzheimer's dementia, in a subject in need thereof, said method comprising administering to said subject a therapeutically effective amount of a composition comprising tahina and probiotic bacteria,
- wherein said composition is formulated for oral administration;
- and said tahina has been microfluidized by passing through a fixed-geometry homogenization channel at a pressure of at least 5000 PSI.
Dependencies are inferred from the claim text.